Alzheon: Alzheon's Alzheimer's pill fails in Phase III trial
Alzheon's Alzheimer's drug showed nominal benefit in a subgroup of patients who suffer with mild cognitive impairment. The post Alzheon's Alzheimer's pill fails in Phase III trial appeared first on Clinical Trials Arena.
Read full article »
Alzheon is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of Alzheimer’s disease and neurological disorders.
Read more